June 27, 2023 0:52 (London Time)

AbCellera Biologics

Youtube Subscribe

Sector: Biotechnology

Ticker: ABCL

Sentiment: 0.4404

MarketCap: 2,110,602,367.0

High: 7.34 Low: 6.9

Open: 7.28 Close: 6.91 Change: -0.37

What an AI can tell you about AbCellera Biologics Company Inc Stock before investing.

This document will help you to evaluate AbCellera Biologics without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbCellera Biologics are: year, day, month, Inc, ABCL, AbCellera, Biologics, …

Concept Map

Semantic Network

Stock Summary

AbCellera Biologics Inc. builds engine for antibody drug discovery and development. Engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. Company had discovery programs that are either completed, in progress, or.

Today's Summary

AbCellera Biologics Inc. (ABCL) offers development of antibody therapeutics to improve patient outcomes. Insiders added US$4.2m of stock to their holdings last year. AbCellera Biologics Inc. (NAS) ABCL, AbCeller Biologicics Inc., ABCL Quick Chart - (NAS)s stock price - BigCharts.com 1 day 2 days 2 days 5 days 10 days -- 1 month 2 months 3 months 6 months YTD 1 year 2 years 3 years 4 years 5 years 1 decade.

Today's News

Stock Profile

"AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company had discovery programs that are either completed, in progress, or under contract with partners. It has a research collaboration and license agreement with Eli Lilly and Company; and a research collaboration with Confo Therapeutics for the discovery of therapeutic antibody candidates targeting two undisclosed GPCR targets. The company was incorporated in 2012 and is headquartered in Vancouver, Canada."

Keywords

Are looking for the most relevant information about AbCellera Biologics? Investor spend a lot of time searching for information to make investment decisions in AbCellera Biologics. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbCellera Biologics are: year, day, month, Inc, ABCL, AbCellera, Biologics, and the most common words in the summary are: state, united, therapeutic, follow, nasdaq, abcellera, biologics, . One of the sentences in the summary was: Insiders added US$4.2m of stock to their holdings last year. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #state #united #therapeutic #follow #nasdaq #abcellera #biologics.

November 16, 2023 0:28 (London Time)